Stock data
Tandem Diabetes Care, Inc. (TNDM)
Tandem Diabetes Care, Inc. (TNDM) reported revenue of US$1.01B and net income of -US$204.71M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$1.01B | US$546.01M | -US$187.26M | -US$204.71M | — |
| 2024 | US$940.20M | US$489.57M | -US$99.13M | -US$96.03M | — |
| 2023 | US$747.72M | US$367.69M | -US$233.23M | -US$222.61M | — |
| 2022 | US$801.22M | US$412.99M | -US$92.85M | -US$94.59M | — |
| 2021 | US$702.80M | US$376.21M | US$22.65M | US$15.57M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$254.56M | -US$21.17M | — |
| 2026-03-31 | US$247.22M | -US$20.39M | — |
| 2025-12-31 | US$290.38M | -US$0.59M | — |
| 2025-09-30 | US$249.25M | -US$21.16M | — |
| 2025-06-30 | US$240.68M | -US$52.40M | — |
| 2025-03-31 | US$234.42M | -US$130.56M | — |
| 2024-12-31 | US$282.65M | US$0.76M | — |
| 2024-09-30 | US$243.97M | -US$23.25M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.